Medivolve Inc
OTC:MEDVF
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.003
0.05
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one MEDVF stock under the Base Case scenario is 0.004 USD. Compared to the current market price of 0.007 USD, Medivolve Inc is Overvalued by 45%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Medivolve Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for MEDVF cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Medivolve Inc
Balance Sheet Decomposition
Medivolve Inc
Current Assets | 904.3k |
Cash & Short-Term Investments | 400.6k |
Receivables | 295.9k |
Other Current Assets | 207.8k |
Non-Current Assets | 858.9k |
PP&E | 373.4k |
Intangibles | 485.5k |
Current Liabilities | 18.9m |
Accounts Payable | 9.2m |
Accrued Liabilities | 4.1m |
Short-Term Debt | 1.6m |
Other Current Liabilities | 3.9m |
Non-Current Liabilities | -281.2k |
Other Non-Current Liabilities | -281.2k |
Earnings Waterfall
Medivolve Inc
Revenue
|
975.2k
CAD
|
Cost of Revenue
|
-137.4k
CAD
|
Gross Profit
|
837.8k
CAD
|
Operating Expenses
|
-4.7m
CAD
|
Operating Income
|
-3.8m
CAD
|
Other Expenses
|
-13.8m
CAD
|
Net Income
|
-17.6m
CAD
|
Free Cash Flow Analysis
Medivolve Inc
CAD | |
Free Cash Flow | CAD |
MEDVF Profitability Score
Profitability Due Diligence
Medivolve Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
Score
Medivolve Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
MEDVF Solvency Score
Solvency Due Diligence
Medivolve Inc's solvency score is 30/100. The higher the solvency score, the more solvent the company is.
Score
Medivolve Inc's solvency score is 30/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MEDVF Price Targets Summary
Medivolve Inc
Dividends
Current shareholder yield for MEDVF is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Medivolve, Inc. engages in seeking technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate risk-adjusted returns for investors. The company is headquartered in Toronto, Ontario. The company went IPO on 2009-11-16. The firm is engaged in providing telehealth platform, a clinical diagnostic network, and a data driven artificial intelligence (AI) framework to improve patient care. The company offers a network of retail collection sites, which provides clinical services in diagnostic testing, vaccinations, and other point-of-care services. The company is also engaged in developing technologies to identify, treat, and prevent medical issues. The company provides solution in COVID-19 testing, immunity scoring, and vaccinations. Its COVID-19 Testing includes rapid antibody blood test, reverse transcription (RT)- polymerase chain reaction (PCR) test and antigen test. The firm uses channel partner Aditxt Therapeutics, Inc. (Aditxt) to offer COVID-19 immunity status monitoring through its mobile testing centers.
Contact
IPO
Employees
Officers
The intrinsic value of one MEDVF stock under the Base Case scenario is 0.004 USD.
Compared to the current market price of 0.007 USD, Medivolve Inc is Overvalued by 45%.